Business
Australian Clinical Labs terms: $408.6m IPO at $4 a share – The Australian Financial Review
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
The brokers equities desks sent terms to fund managers on Wednesday morning, and said they would be back with an institutional bookbuild to sell shares and lock in the listing on Tuesday April 27.
Street Talk. Erin Jonasson
The term sheet said Australian Clinical Labs would seek to raise $408.6 million at $4 a share.
The price represented 15-times forecast profit for the 2021 calendar…
-
General21 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
Noosa News11 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News20 hours agoE-Scooter accident | Noosa Today
-
General23 hours agoOscars to move to free streaming on YouTube in 2029